26.02.2016 • News

Bayer Mum on Covestro Drawdown Plan

Bayer has refused to be drawn on when it plans to reduce the 69% stake it holds in Covestro, the former Bayer MaterialScience, following the flotation of 31% on the stock market in September 2015.

In response to questions at the annual results press conference in Leverkusen on Feb. 25, the German group’s chief financial officer, Johannes Dietsch, said there is no current timetable for a drawdown. However, he stressed that the former Bayer subgroup is purely a financial investment.

A complete pullback is still on track for the medium term, Dietsch said.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.